Luis Paz-Ares
MD, PhD
Head of the Oncology Department
👥Biography 个人简介
Dr. Luis Paz-Ares is one of Europe's most distinguished thoracic oncologists and has been a principal investigator in the KEYNOTE-407 trial establishing pembrolizumab plus chemotherapy as first-line therapy for squamous NSCLC. He has led landmark trials in lung cancer including IMpower110 and multiple SCLC combination studies. His contributions span squamous and non-squamous NSCLC as well as SCLC immunotherapy.
🧪Research Fields 研究领域
🎓Key Contributions 主要贡献
Representative Works 代表性著作
📄Data Sources 数据来源
Last updated: 2026-04-01 | All information from publicly available academic sources
Related Experts 相关专家
Antoni Ribas
UCLA Jonsson Comprehensive Cancer Center
Drew M. Pardoll
Johns Hopkins University
Padmanee Sharma
MD Anderson Cancer Center
Naiyer A. Rizvi
Columbia University Irving Medical Center
关注 Luis Paz-Ares 的研究动态
Follow Luis Paz-Ares's research updates
留下邮箱，当我们发布与 Luis Paz-Ares（Hospital Universitario 12 de Octubre）相关的新研究或访谈时，我们会通知你。
Explore More Experts
Discover the researchers shaping the future of cancer treatment